Chung Jin Biotech Acquires Patent for Bee Venom Cosmetics Brand MEDIBEE with its Outstanding Technology

Korea’s first FDA DMF 27321-certified purified bee venom

ANSAN, South Korea–(BUSINESS WIRE)–#BeeVenom–Chung Jin Biotech Co., Ltd, a company specializing in bee venom, has obtained a patent for the bee venom cosmetics brand ‘MEDIBEE’ with its 20 years of top-tier technology.

‘MEDIBEE’ has successively developed and produced masks, serums, patches, and creams. All MEDIBEE brand cosmetics contain the optimal ratio of bee venom peptides, setting them apart from other products.

‘MEDIBEE Repair Intensive Cream’ helps hydrate, improve wrinkles, and strengthen the skin barrier with eco-friendly components like plant extracts and purified bee venom. The main ingredients of the intensive cream include purified bee venom, which received FDA DMF 27321 certification for the first time in Korea, shea butter, and ceramide.

This cream-type product boasts a hypoallergenic, soft texture, anti-aging, whitening, and wrinkle care benefits. The creamy texture applies smoothly and quickly absorbs deep into the skin to provide moisturizing over time and a refreshing finish without being sticky or rubbed off.

Chung Jin Biotech exports its products to numerous regions, such as the Americas, Europe, the Middle East, Asia, and Oceania, and has also acquired overseas certifications such as CPNP and HALAL (vary by product).

For more information about Chung Jin Biotech and MEDIBEE, visit http://www.biovenom.com/ and https://www.medibee.org/.

Contacts

EDL ENTERPRISE for Chung Jin Biotech Co., Ltd

Sujin Lee

lsj@edl.co.kr